title: Biogenic amines and their metabolites are differentially affected in the Mecp2-deficient mouse brain.
abstract: BACKGROUND
  Rett syndrome (RTT, MIM #312750) is a severe neurological disorder caused by mutations in the X-linked methyl-CpG binding protein 2 (MECP2) gene. Female patients are affected with an incidence of 1/15000 live births and develop normally from birth to 6-18 months of age before the onset of deficits in autonomic, cognitive, motor functions (stereotypic hand movements, impaired locomotion) and autistic features. Studies on Mecp2 mouse models, and specifically null mice, revealed morphological and functional alterations of neurons. Several functions that are regulated by bioaminergic nuclei or peripheral ganglia are impaired in the absence of Mecp2.
  
  
  RESULTS
  Using high performance liquid chromatography, combined with electrochemical detection (HPLC/EC) we found that Mecp2(-/y) mice exhibit an alteration of DA metabolism in the ponto-bulbar region at 5 weeks followed by a more global alteration of monoamines when the disease progresses (8 weeks). Hypothalamic measurements suggest biphasic disturbances of norepinephrine and serotonin at pathology onset (5 weeks) that were found stabilized later on (8 weeks). Interestingly, the postnatal nigrostriatal dopaminergic deficit identified previously does not parallel the reduction of the other neurotransmitters investigated. Finally, dosage in cortical samples do not suggest modification in the monoaminergic content respectively at 5 and 8 weeks of age.
  
  
  CONCLUSIONS
  We have identified that the level of catecholamines and serotonin is differentially affected in Mecp2(-/y) brain areas in a time-dependent fashion.
authors: INSERM UMR_S 910, Unité de Génétique Médicale et Génomique Fonctionnelle, Equipe de Neurogénétique Humaine, France. nicolas.panayotis@univmed.fr
authors: Nicolas
authors: N
authors: Panayotis
authors: Adeline
authors: A
authors: Ghata
authors: Laurent
authors: L
authors: Villard
authors: Jean-Christophe
authors: JC
authors: Roux
references: Neuropsychopharmacology. 2006 Nov;31(11):2332-40
references: 16855535
references: Respir Physiol. 1995 Sep;101(3):219-30
references: 8606995
references: Neuron. 2007 Nov 8;56(3):422-37
references: 17988628
references: J Physiol. 1998 Jul 15;510 ( Pt 2):527-33
references: 9706001
references: Cell Mol Neurobiol. 2002 Dec;22(5-6):835-44
references: 12585701
references: Neuropharmacology. 2004 Jun;46(8):1130-40
references: 15111020
references: Cell. 2009 Sep 4;138(5):976-89
references: 19737523
references: Exp Biol Med (Maywood). 2011 Jan;236(1):3-19
references: 21239731
references: Neuropeptides. 2009 Aug;43(4):275-82
references: 19576631
references: Ann Neurol. 2010 Dec;68(6):944-50
references: 21154482
references: Nat Rev Neurosci. 2009 Mar;10(3):211-23
references: 19190638
references: Brain Res. 2010 Mar 4;1317:87-91
references: 20036647
references: Mol Cell Neurosci. 2009 Aug;41(4):440-7
references: 19409492
references: Neuroscience. 2002;111(4):815-35
references: 12031406
references: Behav Brain Res. 2011 Jan 1;216(1):313-20
references: 20713094
references: Neuroscience. 2010 Feb 17;165(4):1254-60
references: 19932741
references: J Neural Transm (Vienna). 2003 Jan;110(1):51-65
references: 12541012
references: Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21966-71
references: 20007372
references: Biochem Pharmacol. 2008 Jan 1;75(1):85-97
references: 17686465
references: Nat Genet. 2001 Mar;27(3):322-6
references: 11242117
references: Auton Neurosci. 2011 Apr 26;161(1-2):55-62
references: 21316312
references: Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):2029-34
references: 19208815
references: J Neurosci. 2005 Dec 14;25(50):11521-30
references: 16354910
references: Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12560-5
references: 16116096
references: Respir Physiol Neurobiol. 2009 Aug 31;168(1-2):101-8
references: 19394452
references: Nat Genet. 1999 Oct;23(2):185-8
references: 10508514
references: Neuroscience. 2010 Oct 13;170(2):453-67
references: 20633611
references: J Neurosci. 2007 Jul 4;27(27):7344-60
references: 17611287
references: Neuron. 2008 Sep 25;59(6):947-58
references: 18817733
references: Nat Rev Neurosci. 2001 Jan;2(1):24-32
references: 11253356
references: Behav Genet. 2010 Jan;40(1):59-75
references: 19851857
references: Neuron. 2006 Feb 2;49(3):341-8
references: 16446138
references: Neurobiol Dis. 2011 Feb;41(2):385-97
references: 20951208
references: J Pediatr. 2006 Mar;148(3):347-52
references: 16615965
references: J Neurosci. 1996 Sep 1;16(17):5361-71
references: 8757249
references: J Neurosci. 2009 Sep 30;29(39):12187-95
references: 19793977
references: Eur J Paediatr Neurol. 2002;6(5):293-7
references: 12378695
references: Neurosci Lett. 2005 Sep 23;386(1):14-7
references: 15975715
references: Nat Genet. 2001 Mar;27(3):327-31
references: 11242118